Unlock Premium Data: Up to 50% Off InvestingProCLAIM SALE

Stericycle, MarineMax, Agios Pharmaceuticals And Other Big Stocks Moving Higher On Monday

Published 03/06/2024, 15:39
Updated 03/06/2024, 16:40
© Reuters.  Stericycle, MarineMax, Agios Pharmaceuticals And Other Big Stocks Moving Higher On Monday
ADSK
-
SRCL
-
WM
-
GME
-
ARWR
-
COHR
-
GERN
-
NVAX
-
SKYW
-
TDS
-
HZO
-
AGIO
-
AMC
-
PGRE
-
SMMT
-
NTLA
-
ELF
-
DNLI
-
LQDA
-
TWST
-

Benzinga - by Avi Kapoor, Benzinga Staff Writer.

U.S. stocks were mixed, with the Dow Jones index falling around 100 points on Monday.

Shares of Stericycle, Inc. (NASDAQ:SRCL) rose sharply during Monday's session after the company inked a deal to be acquired by Waste Management Inc. (NYSE:WM) for approximately $7.2 billion, including debt.

Stericycle shares climbed 15% to $59.28 on Monday.

Here are some other big stocks recording gains in today’s session.

  • GameStop Corp. (NYSE:GME) shares jumped 34.5% to $31.13 after Roaring Kitty on a Reddit post, shared his position on the stock.
  • MarineMax, Inc. (NYSE:HZO) jumped 27% to $36.16. OneWater Marine Inc. is reportedly said to be in advanced discussions to acquire MarineMax.
  • Liquidia Corporation (NASDAQ:LQDA) shares jumped 16.8% to $15.03 as the company said District Court issued favorable ruling and denied United Therapeutics’ request to block YUTREPIA™ launch.
  • Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) gained 15.5% to $11.18.
  • Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) gained 13.7% to $41.30 as the company reported Phase 3 results for mitapivat in reducing thalassemia transfusions.
  • Coherent Corp. (NASDAQ:COHR) rose 13.4% to $64.71 after the company announced the appointment of Jim Anderson as CEO.
  • CG Oncology, Inc. (NASDAQ:CGON) gained 11.8% to $36.34
  • Structure Therapeutics Inc. (NASDAQ:GPCR) gained 11.8% to $38.25 after the company reported 12-week results for obesity drug GSBR-1290, achieving significant weight loss.
  • Intellia Therapeutics, Inc. (NASDAQ:NTLA) rose 11.8% to $23.9 after the company announced long-term data from the Phase 1 portion of the ongoing Phase 1/2 study of NTLA-2002..
  • AMC Entertainment Holdings, Inc. (NYSE:AMC) climbed 11.6% to $4.8330. The resumption of the meme rally came on the back of Keith Gill, also known as "Roaring Kitty," disclosing a substantial position in GameStop on the r/Superstonk Reddit forum.
  • Novavax, Inc. (NASDAQ:NVAX) rose 10.7% to $16.65.
  • Twist Bioscience Corporation (NASDAQ:TWST) gained 9.8% to $45.99.
  • Geron Corporation (NASDAQ:GERN) climbed 9.2% to $3.8750.
  • Telephone and Data Systems, Inc. (NYSE:TDS) climbed 9% to $21.67 as the company agreed to sell its wholly owned subsidiaries OneNeck IT Solutions and OneNeck Data Center to US Signal Company, LLC.
  • Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) rose 8.9% to $24.99 as the company reported topline results from pivotal Phase 3 PALISADE study of investigational plozasiran.
  • Summit Therapeutics Inc (NASDAQ:SMMT) gained 8.8% to $9.45.
  • SkyWest, Inc. (NASDAQ:SKYW) jumped 8.4% to $80.97.
  • Autodesk, Inc. (NASDAQ:ADSK) rose 8.3% to $218.39 after the company issued preliminary results and said there will be no restatement or adjustment of any audited or unaudited financial statements.
  • Denali Therapeutics Inc. (NASDAQ:DNLI) jumped 8.1% to $20.06 as the company said that the FDA has selected DNL126 for participation in support for clinical trials advancing rare disease therapeutics pilot program.
  • Vera Therapeutics, Inc. (NASDAQ:VERA) gained 7.3% to $40.75.
  • Paramount Global (NASDAQ:PARA) rose 7.1% to $12.76 following reports suggesting Skydance is poised to announce the takeover of Paramount.
  • e.l.f. Beauty, Inc. (NYSE:ELF) gained 7% to $199.99. DA Davidson analyst Linda Bolton Weiser maintained e.l.f. Beauty with a Buy and maintained a $220 price target.
  • Arm Holdings plc (NASDAQ:ARM) rose 5% to $126.55 after the broader sector selloff on Friday when the U.S. government imposed sanctions on the Middle East regarding AI chips.
Now Read This: $20M Bet On This Energy Stock? Check Out These 3 Stocks Insiders Are Buying

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.